4//SEC Filing
NxStage Medical, Inc. 4
Accession 0001209191-14-068274
CIK 0001333170operating
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 6:58 PM ET
Size
8.4 KB
Accession
0001209191-14-068274
Insider Transaction Report
Form 4
Hershberger Kevin
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2014-11-12$9.96/sh+7,824$77,927→ 32,541 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-11-12−7,824→ 12,576 totalExercise: $9.96From: 2010-04-03Exp: 2017-03-02→ Common Stock (7,824 underlying) - Sale
Common Stock
2014-11-12$16.58/sh−11,056$183,308→ 21,485 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2014.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333170
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 6:58 PM ET
- Size
- 8.4 KB